Page last updated: 2024-11-05

5-methylchrysene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-Methylchrysene is a polycyclic aromatic hydrocarbon (PAH) that has been identified as a component of coal tar and other environmental sources. It is of interest to researchers due to its potential carcinogenic properties. Its synthesis can be achieved through various organic chemistry techniques involving reactions like Friedel-Crafts alkylation. Studies investigating its effects have focused on its mutagenic and carcinogenic activity in biological systems, highlighting its potential health risks. Further research aims to understand its metabolism, environmental persistence, and the mechanisms by which it exerts its biological effects. These investigations are important for assessing its potential risks to human health and the environment.'

5-methylchrysene: methylchrysenes in tobacco smoke are suspected to contribute to tumorigenicity of this inhalant; RN given refers to unlabeled cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID19427
CHEMBL ID1797269
CHEBI ID82342
MeSH IDM0052262

Synonyms (32)

Synonym
ccris 387
5-methyl chrysene
hsdb 6979
brn 2048519
nsc 407620
nsc407620
wln: l e6 b666j c1
5-methylchrysene
nsc-407620
chrysene, 5-methyl-
3697-24-3
CHEMBL1797269
chebi:82342 ,
C19259
o66195mc8l ,
unii-o66195mc8l
FT-0634977
5-methylchrysene [iarc]
methylchrysene, 5-
5-methylchrysene [hsdb]
AKOS025243240
DTXSID6063143
20-hydroxyecdysone22-acetate
5-methylchrysene #
GOHBXWHNJHENRX-UHFFFAOYSA-N
5-methylchrysene, bcr(r) certified reference material
chrysene, 5-methyl-; 5-methylchrysene; nsc 407620
5-methylchrysene 10 microg/ml in cyclohexane
5-methylchrysene 10 microg/ml in acetonitrile
Q27155887
5-methyl-chrysene
PD017430

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Although a major attention has been in past paid especially to mutagenic, tumor-initiating effects of MeChry, little is known about toxic effects of MeChry related to tumor promotion."( Effects of methylated chrysenes on AhR-dependent and -independent toxic events in rat liver epithelial cells.
Kozubík, A; Krcmár, P; Machala, M; Milcová, A; Nováková, Z; Pencíková, K; Svihálková-Sindlerová, L; Topinka, J; Vondrácek, J, 2008
)
0.35
" These studies show that the relative efficacy of protection by hGSTP1 against mutagenicity of 5MC or 5MC-1,2-diol is in part determined by the specific CYP pathway that catalyzes activation to the toxic or mutagenic metabolites."( Cytotoxicity and mutagenicity of 5-methylchrysene and its 1,2-dihydrodiol in V79MZ cells modified to express human CYP1A1 or CYP1B1, in the presence or absence of human GSTP1 coexpression.
Ahmad, S; Amin, S; Doehmer, J; Kabler, SL; Morrow, CS; Rudd, L; Townsend, AJ, 2008
)
0.63
"Polycyclic aromatic hydrocarbons (PAHs) comprise a large family of toxic compounds that come from natural and anthropogenic sources."( Aryl hydrocarbon receptor signaling, toxicity, and gene expression responses to mono-methylchrysenes.
Alqassim, AY; Miller, CA; Overton, EB; Pangeni, D; Wickliffe, JK; Wilson, MJ, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" A clear dose-response effect on formation of DNA adducts was obtained for B[a]P and a Standard Reference Material (SRM) of diesel particulate matter."( Time- and dose-dependent DNA binding of PAHs derived from diesel particle extracts, benzo[a]pyrene and 5-methychrysene in a human mammary carcinoma cell line (MCF-7).
Isotalo, S; Kuljukka-Rabb, T; Mikkonen, S; Peltonen, K; Rantanen, L; Savela, K, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carbopolycyclic compoundA polyclic compound in which all of the ring members are carbon atoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
AID1123553Mutagenic activity in Salmonella typhimurium TA 100 at 5 to 100 ug by Ames test in presence of Fischer-344 rat liver S9 fraction1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Synthesis and mutagenicity of 5,11-dimethylchrysene and some methyl-oxidized derivatives of 5-methylchrysene.
AID1123557Toxicity in Salmonella typhimurium TA 100 at 5 to 100 ug in presence of Fischer-344 rat liver S9 fraction1979Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
Synthesis and mutagenicity of 5,11-dimethylchrysene and some methyl-oxidized derivatives of 5-methylchrysene.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (48.84)18.7374
1990's11 (25.58)18.2507
2000's6 (13.95)29.6817
2010's5 (11.63)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.00 (24.57)
Research Supply Index3.83 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index22.84 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]